HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation - Wikidata - awgldk - TriplyDB

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

http://www.wikidata.org/entity/Q36907933

about

MiR-210--micromanager of the hypoxia pathway Hypoxia-inducible factors and the response to hypoxic stress Targeting Cancer Metabolism - Revisiting the Warburg Effects Clinical significance of T cell metabolic reprogramming in cancer Targeting metabolism in breast cancer: How far we can go?Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes Interplay Between Metabolism and Oncogenic Process: Role of microRNAs Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1 Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction Cancer metabolism: key players in metabolic reprogramming Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks HypoxamiRs and cancer: from biology to targeted therapy Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming Nutrient-sensing pathways and metabolic regulation in stem cells Nutrient sensing, metabolism, and cell growth control Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis Imaging metabolic heterogeneity in cancer Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer Identification of the Lipodepsipeptide MDN-0066, a Novel Inhibitor of VHL/HIF Pathway Produced by a New Pseudomonas Species Exposure to nickel, chromium, or cadmium causes distinct changes in the gene expression patterns of a rat liver derived cell line Activation of a metabolic gene regulatory network downstream of mTOR complex 1 The impact of O2 availability on human cancer Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin.Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer.Hypoxia induces differential translation of enolase/MBP-1.Tetravalent antibody-scTRAIL fusion proteins with improved properties.Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.Molecular mechanisms of hypoxia in cancer.Cdc6 contributes to abrogating the G1 checkpoint under hypoxic conditions in HPV E7 expressing cells.Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma.In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.

P2860

Q24628401-53AC7338-9179-41FC-9D16-7BDD95635B3D Q24629323-CD846AF7-6C46-4B64-9FB8-E0B5AF749E54 Q26738876-A27AD960-5EBF-4835-9F79-9C15636B38D3 Q26741974-032E683C-40FE-4F06-8F6A-6D3F9A18043F Q26767022-6502DDCC-4EC7-4F04-885C-FA5565DF64B6 Q26767183-6EA35708-7222-4D1E-93A3-A3D31691E124 Q26770381-2C6958DC-1D37-4023-B62A-A7557050B347 Q26778530-B86A30A9-4F72-4AB5-8633-DD6293F639AE Q26778957-35947F1F-38A4-4BA0-ACA7-B0F00E34D3BC Q26786610-0EEF0F7A-2CEB-4B84-B36F-BABD7DDAFE87 Q26827663-09DD6C6D-2AA1-4750-BA7E-C86805CB936E Q26853482-9A1BD3B5-D96F-400B-B070-48448A645BF6 Q26863298-3431C8B3-8018-49E1-A9DF-41D0B0A452D5 Q26991931-E72EE1A0-A9AD-4B21-9677-DB6FD59CE745 Q27011433-B944741C-8A25-406E-965E-508B33621268 Q27024772-FF28C93F-3DCA-463B-93BE-7F2C0C2B1673 Q28075646-F4CA07B2-43C7-4F19-9512-C54E416A0D0E Q28076500-AD024EDA-4C98-4D9E-A697-67A40B37A298 Q28081657-A5EC149E-AD4A-4E67-8406-139E32997872 Q28304473-61F4CF44-F56F-4F71-963C-1A66D62A6CC4 Q28481429-97ACCE53-7829-41C0-81E7-FF962D1D9D5C Q28486165-26CD34D7-4B52-4A15-9684-2637B4833804 Q28547505-1E075670-AAA0-44C7-9853-4A69DAA9255E Q28742638-A6010C9D-C761-4E2E-B441-1FE15B9278D3 Q29615179-562369C6-3B94-40D7-A22B-ABA1D66D223F Q29619884-5898F8E4-8612-416B-8D1F-098828BEE5A7 Q30316645-11FD384D-D163-44D7-B545-700A0EE39878 Q30572396-27F43E64-2176-472F-AAD9-ACCBD1ED6878 Q30932207-5A84A88C-82DD-4DA1-9C0C-F4A04827A70D Q33384384-2A99E2C3-4B98-4CA0-8525-D2A38D4D9D24 Q33412131-D4D8E4AD-AE91-46A8-B79A-21439569D7C8 Q33562305-E70E829C-8E60-44E4-832D-1649EFF62ACC Q33619046-F7C55A7A-8DEF-46CB-BDF6-01B99321DF7D Q33641532-E710F3EC-9181-4AB8-8AA3-7449EA7A3DBC Q33685179-9A3BF2AA-CD09-48B3-A908-F576E3B7CD5E Q33705108-AB3E58F9-5D29-41EE-A7DB-B54308A245C5 Q33774265-C5C08376-38C2-4A9A-A5B7-3D47BC287E5C Q33786677-47C606AF-CA3B-497F-83B8-B27B4C9FE2A5 Q33804675-9E44173F-4A88-4DE1-8AA7-25EC9F986DCD Q33805335-C47CD3A1-1941-45B5-9612-388231D93629

P2860

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

http://www.wikidata.org/entity/Q36907933

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

@en

type

label

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

@en

prefLabel

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

@en

P1433

Q36907933-FD74F8CD-E20D-4B04-9976-1E7E88F3DDF0

P1476

Q36907933-76859155-801C-4B6A-842C-B079C626F660

P2093

Q36907933-4EAF483D-4DDF-4EC8-A399-6B3510D130BA

Q36907933-DAA47021-3083-4B1E-ACA6-EFDAC051CA0D

Q36907933-E1EDB092-01C8-4E2B-BCEC-08999BDD6190

P2860

Q36907933-03993659-62C3-466E-9030-74DCC0E4963C

Q36907933-0A989EDD-96B0-4EC7-86EE-AA26D372FD46

Q36907933-154A72AB-B5BB-42E9-A7C7-C54BF8516C66

Q36907933-1588C006-4235-42E1-8223-B1A177BD397C

Q36907933-175CD387-FB63-48F2-881F-92914CE047E6

Q36907933-182244D4-1BE3-44B6-9E9F-A1C822574329

Q36907933-1B1A6149-4CD3-40BC-8665-E6CD368F9E4C

Q36907933-2009447B-544E-4E00-AF5F-49EBA2430CA2

Q36907933-2A1C7CEF-6064-44EF-AFF6-BA89FC7F0118

Q36907933-301D2B0A-68EE-484F-916F-5578D12B5269

P304

Q36907933-05CDE90E-9F41-48F1-B25C-01BBC19A001B

P31

Q36907933-99C34A78-72D6-4977-B522-25B1987BB04A

P356

Q36907933-0C8F44CB-BDDD-4D13-ACB1-B918D19010C6

P433

Q36907933-8CDE37EA-D10D-45E5-80E8-430C8D36C502

P478

Q36907933-AFC9E805-95E7-43A0-8F91-DED2C897AFE3

P577

Q36907933-8A95ECF4-ED1D-4FE6-A905-35D8B14FC544

P5875

Q36907933-BE32502E-52C0-45DB-93DF-129C1EC040C2

P698

Q36907933-CA8339D4-ED6C-49DB-ACCB-754923569CED

P921

Q36907933-F71A2C97-8AFE-473F-BF54-CB4025A74AC6

P932

Q36907933-8109C169-C996-4763-937E-A6DAAC5F63BD

P356

J.CCR.2007.07.006

P1433

P1476

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

@en

P2093

Craig B Thompson

http://www.w3.org/2001/XMLSchema#string

John D Gordan

http://www.w3.org/2001/XMLSchema#string

M Celeste Simon

http://www.w3.org/2001/XMLSchema#string

P2860

Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC

The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation

PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR

HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity

HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells

Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control.

The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression

Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha.

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

Targeting HIF-1 for cancer therapy

P304

108-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2007.07.006

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6146396

http://www.w3.org/2001/XMLSchema#string

P698

17692803

http://www.w3.org/2001/XMLSchema#string

P921

P932

3215289

http://www.w3.org/2001/XMLSchema#string